Roivant Sciences Ltd. Common Shares vs State Street PDR S&P Retail ETF — how do they compare? Roivant Sciences Ltd. Common Shares trades at $34.44 (market cap $24.72B), while State Street PDR S&P Retail ETF trades at $83.76 (market cap $389.66M). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 63.4× State Street PDR S&P Retail ETF's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, State Street PDR S&P Retail ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Roivant Sciences Ltd. Common Shares for 0 Days and State Street PDR S&P Retail ETF for 44 Days on average.
| ROIV | XRT | |
|---|---|---|
Market Cap | $24.72B | $389.66M |
Volume | 6,279,442 | 4,275,820 |
Sector | Health | Broad Market / Factor |
52-Week High | $41.81 | $92.35 |
52-Week Low | $16.04 | $77.28 |
Typical Hold Time | 0 Days | 44 Days |
Enterprise Value | $20.99B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XRT (SPDR S&P Retail ETF) trades at $82.91, showing minimal daily movement with a slight decline of 0.05%. Technical indicators signal a bearish trend overall, with moving averages particularly negative. The ETF faces headwinds from higher interest rates and inflation impacting consumer spending, though recent retail sales data showed a strong August rebound. Analyst sentiment remains cautious with expectations of continued underperformance against broader market indices.
The retail sector faces macroeconomic pressures including inflation and rising rates that weigh on consumer discretionary spending. While holiday sales projections exceed $1 trillion, selective consumer behavior favors value-oriented retailers. Near-term performance depends on Fed policy direction and consumer resilience during the critical holiday season, with technical resistance at $83-$84 levels limiting upside potential.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →XRT is an equal-weighted ETF that tracks the U.S. retail sector. It provides diversified exposure to apparel, automotive, and online retailers, including well-known names like Amazon, Target, and Costco.
Read more on XRT →